Replimune Group, Inc. (REPL)

7.60 -0.30 (-3.80%) USD  |  NASDAQ  |  Jan 23, 11:58
More

Replimune Group Extraordinary Items, Income Statement (Quarterly)

Extraordinary Items, Income Statement (Quarterly) Chart

View Extraordinary Items, Income Statement (Quarterly) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Extraordinary Items, Income Statement (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years

View Extraordinary Items, Income Statement (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Extraordinary Items, Income Statement (Quarterly) Benchmarks

View Extraordinary Items, Income Statement (Quarterly) Benchmarks
Start Trial
Rapt Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Anavex Life Sciences Corp. Upgrade